|
|
||||||||
Eur J Cardiothorac Surg 2002;21:1111-1114
© 2002 Elsevier Science NL
a General Thoracic Surgery, Department of General Surgery, Catholic University of Rome, Rome, Italy
b Department of Radiology, Catholic University of Rome, Rome, Italy
Received 23 September 2001; received in revised form 4 February 2002; accepted 20 February 2002.
* Corresponding author. Division of General Thoracic Surgery, Department of Surgical Sciences, Catholic University of Rome, Largo A. Gemelli 8, 00168 Roma, Italia. Tel.: +39-335-6591209; fax: +39-06-3051162
e-mail: venanzioporziella{at}hotmail.com
| Abstract |
|---|
|
|
|---|
Key Words: Pulmonary metastases Surgical treatment CT scan
| 1. Introduction |
|---|
|
|
|---|
Some authors [57] have recently remarked that the helical CT (HCT) scan has been shown to be superior to the conventional CT scan in detecting pulmonary metastases; therefore, the VATS approach to pulmonary metastases has been re-proposed as a less invasive and curative technique, especially in selected patients.
In this retrospective study, we evaluated the effectiveness of radiological preoperative assessment (conventional and high-resolution CT (HRCT) scan vs. HCT scan) of lung metastases. The end points were the sensitivity of both techniques and the number of failures to evaluate if VATS is a suitable procedure or if manual palpation of the lung during thoracotomy still remains the most accurate method to detect any lung metastases.
| 2. Materials and methods |
|---|
|
|
|---|
Patients were randomly submitted preoperatively to HRCT scan or HCT scan to assess the number, size and location of the secondary lesions. HRCT scan was performed in 78 patients (51 males and 27 females) included in group A. In the remaining 88 patients (63 males and 25 females) radiological assessment was completed by means of HCT scan (group B). All CT scans were performed with a current generation scanner. In both groups, no IV contrast medium was administered. Images were reconstructed at intervals of 3 mm (HRCT) and 35 mm (HCT).
CT scan images of the first 75 patients studied until June 1998 were analyzed randomly by three different experienced radiologists. In the last 91 patients (39 group A, 52 group B) CT examinations were all interpreted by the same radiologist specializing in thoracic imaging.
Patients undergoing lung metastasectomy were selected according to the following criteria: (a) complete control of the primary tumor; (b) ability to resect all the preoperatively detected metastatic lesions; (c) ability of the patients to withstand the extent of pulmonary resection; (d) absence of extra-thoracic disease; (e) absence of better alternative treatment.
Respiratory function was evaluated in all patients by a spirometric test and hemo-gas-analysis. Perfusional pulmonary scintiscan was performed in patients in whom a major lung resection was likely to be required.
Patients underwent surgical resection 426 days (mean 14 days) after the radiological examination. CT scans older than 4 weeks were repeated. The surgical approach was always a muscle-sparing axillary thoracotomy at the fifth intercostals space, as described by Ginsberg in 1993 [8]. It was staged in case of bilateral lesions, according to our preference described elsewhere [9]. An interval of 34 weeks between the two staged procedures has generally been planned. In seven patients aged over 48 years who underwent staged thoracotomy for bilateral metastasectomies, controlateral lesions were not present on the CT scan at the time of the first side pulmonary resection. In these patients surgery on the opposite lung was performed after a minimum of 4 and a maximum of 15 months since the first thoracotomy.
In the case of synchronous bilateral metastases, the number of metastases in each side (the higher first) was the only selection criteria to decide which side to operate upon first. A double-lumen endotracheal tube was always used for ventilation, permitting isolated deflation of one lung. Accurate palpation of the lung parenchyma was always performed in order to identify any undetected lesion at preoperative radiological study. Every visible or palpable nodule was radically resected through wedge resection or lobectomy. Resected non-metastatic lesions were not considered in this study.
2.1. Statistical analysis
We calculated the sensitivity of HRCT and HCT considering the intraoperative and histologic findings as the gold standard. We excluded resected benign nodules from this analysis, so that specificity could not be calculated. Differences in the numbers of nodules detected were analyzed using the
2-test. Statistical significance was fixed at the 0.05 level (P<0.05).
| 3. Results |
|---|
|
|
|---|
|
Preoperative HRCT scan correctly identified 142 of 188 resected lesions in group A patients. Forty-six metastatic nodules, undetected by radiological procedures, were found and resected after palpatory exploration of the entire lung. HRCT sensitivity was 75%. In group B, HCT scan preoperatively detected 142 of 173 resected metastases. Surgical exploration revealed 31 false-negative findings. HCT sensitivity was 82%.
The sensitivity of CT visibly decreases according to the size of the metastases (Table 2). The sensitivity of HCT exceeded that of HRCT, but this difference did not achieve statistical significance (P>0.05).
|
| 4. Discussion |
|---|
|
|
|---|
VATS has been applied to the treatment of lung metastases since 1992: Landreneau et al. [2] remarked that metastasectomy with a VATS approach offered a less painful incision and a shorter hospital stay, but McCormack et al. [3] identified the potential problems of missing small metastatic lesions with a VATS approach. In their retrospective study, preoperative CT scan underestimated malignant lesions found at thoracotomies in 18 of 72 patients (25%).
In 1995, Liu et al. [10] reported the use of VATS to resect peripheral lung metastases in 47 patients. Digital lung palpation was employed in all cases and identified additional lesions missed at conventional CT in five patients (10.6%). The authors concluded that VATS was ideal to perform therapeutic metastasectomy, but only immediate postoperative results of this study were published.
The observations of McCormack were confirmed by the author herself who described results of the first 18 of 50 patients of a prospective study, which was stopped early because the estimated probability of missing metastases was too high if VATS alone was used (in ten of 18 patients (56%) additional malignant tumors were identified at thoracotomy) [4].
Our experience confirms that preoperative assessment by conventional CT scan is unsatisfactory, even when performed with a high-resolution technique. In our series, CT scan missed 46 of 188 lesions (24%), according to data of other authors. In the studies of Friedmann et al. [11], Chang et al. [12] and van der Veen et al. [13], preoperative conventional CT scan missed, respectively, 17/51 (30%), 45/92 (49%), and 22/78 (28%) metastases found at thoracotomy.
In our experience, additional high-resolution scans provide more accuracy. The sensitivity of the technique is 100% for lesions larger than 1 cm (no false-negatives on 83 metastases), but it visibly decreases according to the size of metastases (66% for lesions <10 mm but >6 mm and 48% for nodules smaller 6 mm). If only lesions >6 mm are considered, the sensitivity is 87% (16/130 false-negatives). These results suggest that preoperative conventional CT scan, even when performed with an additional high-resolution scan, is unsatisfactory.
We do not agree with Mutsaerts et al. [14] who considered video-thoracoscopic resection a viable treatment option for patients with a solitary peripheral pulmonary metastasis. In their study, the subsequent confirmatory thoracotomy found residual disease (one or more nodules) missed by preoperative conventional CT scan and by VATS in five of 17 patients (29%). Their policy seems to be inadequate, because the probability of thoracoscopic resection being complete is only 62%.
However, in recent years some authors have favored the use of VATS for resection of lung metastases. Watanabe et al. [7] in their study on 27 lesions found a sensitivity of 92% for a preoperative scan for patients with one or two lesions. In the review of Lin et al. [5] on 99 potentially curative resections of pulmonary metastases, the authors reported that the results appeared comparable with historical results by thoracotomy (mean survival: 37% at 3 years). To avoid underestimating lesions and compromising therapeutic intent, the authors performed a careful patient selection based on high-resolution HCT scan. Spiral CT scans have been shown [15] to improve the detection of lung nodules eliminating both the respiratory motion artifact and volume averaging. Remy-Jardin et al. [16] compared conventional and spiral CT scans in 39 patients: the mean number of nodules found with the spiral CT scan was significantly higher than the number found with the conventional CT scan (18±4.5 vs. 12.6±3.2).
In our HCTsurgical correlation, the sensitivity of HCT (82%) exceeds that of HRCT, but this difference did not achieve statistical significance (P>0.05). HCT sensitivity also decreased according to the size of metastases: no false-negatives for lesions >10 mm, 11/34 (32%) for lesions <10 mm and >6 mm and 20/52 (38.5%) for lesions <6 mm were observed. The sensitivity of HCT for lesions >6 mm was 91% (11/121 false-negatives). In our experience, HCT has more sensitivity than conventional CT, but has the same limitation in detecting nodules smaller than 6 mm. Similar conclusions were proposed by Diederich et al. [17]: in their CTsurgical correlation on 43 histologically proven metastases, the sensitivity of HCT scan for lesions >6 mm was 95%, but decreased to 69% for lesions smaller than 6 mm.
Waters et al. [18] obtained similar results in their radiological/pathological study performed on four dogs affected with osteosarcoma; the sensitivity of the HCT scan was 91% for lesions >5 mm but 44% for lesions
5 mm.
In the recent experience of Ambrogi et al. [19], manual palpation was able to identify 8/52 metastatic lesions missed at HCT scan (sensitivity 84%).
| 5. Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
| Appendix A. Conference discussion |
|---|
|
|
|---|
Dr Margaritora: No. This was a retrospective study. The number of observed patients is similar in the two groups by chance only. In our hospital there are two CT scans for this kind of patient: one is helical and the other one is for high-resolution CT. The patients have been studied by one or the other only by chance.
Dr Thomas: How did you determine the number of metastases, in collaboration with radiologists?
Dr Margaritora: Yes, sure.
Dr Thomas: You reviewed all the films?
Dr Margaritora: We reviewed all the CT scan films with the radiologists. In the high-resolution CT scan, the slice thickness was 3 mm whilst the helical scans have been realized during the time of one breath only.
Mr D. Waller (Leicester, UK): So your conclusion is that you can't trust the CT scan. You need to palpate the lung?
Dr Margaritora: Yes, this is our conclusion.
Mr Waller: Then do you advocate routine bilateral exploration of the thoracic cavity?
Dr Margaritora: No. We just perform unilateral exploration when we have unilateral evidence of nodules by CT scan.
Mr Waller: So you believe the CT scan?
Dr Margaritora: This is a timely discussed question. We believe that if we have a unilateral lesion in the follow-up of these patients, we have more probability to have other nodules on the same side. Exploring the contralateral side seems an overtreatment. So when we have the evidence of a unilateral disease we think that it is reasonable to realize a limited vertical axillary thoracotomy, as described by Robert Ginsberg. This procedure allows us to perform a complete lung parenchyma palpation.
Dr J. Hasse (Freiburg, Germany): Please, can you comment on the location of those overlooked metastases? Were they subpleurally or were they in the depth of the parenchyma?
Dr Margaritora: In the false negatives cases, the vast majority of the nodules were located deeply into the lung parenchyma and their size was not bigger than 1 cm.
Dr D. Branscheid (Hamburg, Germany): I want to congratulate you because I waited for a paper like that for a long time, and I think a lot of questions have been asked already and they are fantastic and they are very good and they come to one thing. They come to the situation that we need to resect the metastasis radically. This means we have to give the patient a complete remission, a surgical remission. Only then he has a benefit from it. That means we have to perform a median sternotomy or a thoracotomy on the right or a thoracotomy on the left at the same site to give the patient a complete resection. I want to underline that, I want to provoke a little discussion about it, but I think this is mandatory.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Landa and L. H. Schwartz Contemporary Imaging in Sarcoma Oncologist, October 1, 2009; 14(10): 1021 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakas, M. N. Klimatsidas, J. Entwisle, A. E. Martin-Ucar, and D. A. Waller Video-assisted versus open pulmonary metastasectomy: the surgeon's finger or the radiologist's eye? Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 469 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cerfolio, T. McCarty, and A. S. Bryant Non-imaged pulmonary nodules discovered during thoracotomy for metastasectomy by lung palpation Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 786 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nakajima, T. Murakawa, T. Fukami, and S. Takamoto Is thoracoscopic surgery justified to treat pulmonary metastasis from colorectal cancer? Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 212 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kang, C. H. Kang, H. J. Lee, J. M. Goo, Y. T. Kim, and J. H. Kim Accuracy of 16-channel multi-detector row chest computed tomography with thin sections in the detection of metastatic pulmonary nodules Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 473 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cerfolio and A. S. Bryant Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Parsons, E. K. Ennis, B. C. Yankaskas, L. A. Parker Jr, W. B. Hyslop, and F. C. Detterbeck Helical Computed Tomography Inaccuracy in the Detection of Pulmonary Metastases: Can It Be Improved? Ann. Thorac. Surg., December 1, 2007; 84(6): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfannschmidt, H. Dienemann, and H. Hoffmann Surgical Resection of Pulmonary Metastases From Colorectal Cancer: A Systematic Review of Published Series Ann. Thorac. Surg., July 1, 2007; 84(1): 324 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Parsons, F. C. Detterbeck, and L. A. Parker Accuracy of Helical CT in the Detection of Pulmonary Metastases: Is Intraoperative Palpation Still Necessary? Ann. Thorac. Surg., December 1, 2004; 78(6): 1910 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Majhail, J.-L. Urbain, J. M. Albani, M. H. Kanvinde, T. W. Rice, A. C. Novick, T. M. Mekhail, T. E. Olencki, P. Elson, and R. M. Bukowski F-18 Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Distant Metastases From Renal Cell Carcinoma J. Clin. Oncol., November 1, 2003; 21(21): 3995 - 4000. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |